Clinical Trial Update: M-CPP and Fenfluramine in Cocaine Addicts - 3 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating M-CPP in combination with fenfluramine for Cocaine-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Drugs mentioned

• Fenfluramine (fenfluramine)
• m-CPP (meta-Chloro-phenylpiperazine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED